Saxon Interests Inc. Buys 1,136 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Saxon Interests Inc. increased its stake in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 49.4% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 3,437 shares of the healthcare conglomerate's stock after purchasing an additional 1,136 shares during the period. Saxon Interests Inc.'s holdings in UnitedHealth Group were worth $1,738,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors also recently modified their holdings of UNH. International Assets Investment Management LLC grew its holdings in shares of UnitedHealth Group by 78,814.4% in the 3rd quarter. International Assets Investment Management LLC now owns 5,296,737 shares of the healthcare conglomerate's stock valued at $3,096,896,000 after acquiring an additional 5,290,025 shares in the last quarter. Lone Pine Capital LLC bought a new stake in shares of UnitedHealth Group during the 2nd quarter worth approximately $480,903,000. Accredited Investors Inc. grew its stake in shares of UnitedHealth Group by 9,235.4% in the third quarter. Accredited Investors Inc. now owns 784,924 shares of the healthcare conglomerate's stock valued at $458,929,000 after buying an additional 776,516 shares in the last quarter. Raymond James & Associates lifted its stake in UnitedHealth Group by 33.1% in the third quarter. Raymond James & Associates now owns 2,361,396 shares of the healthcare conglomerate's stock valued at $1,380,661,000 after acquiring an additional 587,088 shares during the last quarter. Finally, Caisse DE Depot ET Placement DU Quebec increased its stake in shares of UnitedHealth Group by 129.7% during the 3rd quarter. Caisse DE Depot ET Placement DU Quebec now owns 1,029,540 shares of the healthcare conglomerate's stock worth $601,951,000 after purchasing an additional 581,324 shares during the last quarter. 87.86% of the stock is currently owned by institutional investors.

UnitedHealth Group Price Performance

Shares of NYSE UNH traded down $0.56 during trading hours on Friday, hitting $510.03. 7,462,712 shares of the stock were exchanged, compared to its average volume of 5,104,531. UnitedHealth Group Incorporated has a 1-year low of $436.38 and a 1-year high of $630.73. The company's fifty day simple moving average is $549.37 and its two-hundred day simple moving average is $562.73. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.91. The company has a market cap of $469.37 billion, a PE ratio of 33.23, a price-to-earnings-growth ratio of 1.42 and a beta of 0.62.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, topping analysts' consensus estimates of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The firm had revenue of $100.81 billion during the quarter, compared to analysts' expectations of $101.60 billion. During the same quarter in the prior year, the business earned $5.83 earnings per share. The business's revenue for the quarter was up 6.8% compared to the same quarter last year. On average, sell-side analysts predict that UnitedHealth Group Incorporated will post 27.6 EPS for the current year.

UnitedHealth Group Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th were issued a dividend of $2.10 per share. This represents a $8.40 annualized dividend and a dividend yield of 1.65%. The ex-dividend date of this dividend was Monday, December 9th. UnitedHealth Group's dividend payout ratio (DPR) is currently 54.72%.

Analysts Set New Price Targets

A number of equities analysts have weighed in on UNH shares. Truist Financial lowered their price target on UnitedHealth Group from $625.00 to $610.00 and set a "buy" rating on the stock in a research report on Monday, January 6th. TD Cowen raised their price target on UnitedHealth Group from $601.00 to $609.00 and gave the company a "buy" rating in a report on Friday, October 18th. HSBC raised shares of UnitedHealth Group from a "hold" rating to a "buy" rating and set a $595.00 price objective on the stock in a research report on Friday, January 10th. Barclays lowered their price target on shares of UnitedHealth Group from $655.00 to $642.00 and set an "overweight" rating on the stock in a report on Friday. Finally, Hsbc Global Res raised UnitedHealth Group from a "hold" rating to a "strong-buy" rating in a research report on Friday, January 10th. Two investment analysts have rated the stock with a hold rating, nineteen have given a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat, the company has a consensus rating of "Buy" and an average target price of $627.74.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.